Legacy Healthcare, a Lausanne based biopharma developing innovative botanical drugs in supportive oncology care and dermatology, has raised CHF2m as part of series B financing round. The funds will be used to take Phase II and Phase III drug candidates to the market. The company has two patented cosmetic products against hair loss already on the market, marketed by Abbott, Galderma and Biolab.

Full article